spacer
home > pmps > spring 2009 > confidence in compliance
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

Confidence in Compliance

Patient adherence to medicinal therapy is the prerequisite of any successful treatment. Furthermore, it is the prerequisite for an economical and efficient way of curing illnesses, or improving the general level of human health. Despite this, compliance is not the rule, but the exception. Non-compliance is an issue for individuals whose condition may worsen, or who may even die if they fail to take medication correctly. It is, however, just as much a concern for the public, as non-compliance leads to losses in productivity and increased expenses for modern medication, for better and more efficient drugs. The subsequent cost of non-compliance is not only that of the wasted medicines, but also the cost of emergency and acute intervention when medication is not taken.

The US National Council on Patient Information and Education (NCPIE) states: “Perhaps it is no surprise that one of the most common examples of patients not following their prescription regimen involves antibiotic therapy, usually when they stop taking their medicine prematurely. This can cause a recurrence of the condition that the antibiotics were originally prescribed to treat” (1). What is even more problematic in this instance is that non-compliance can cause the bacteria to become resistant to the initially applied antibiotics.


Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Starting his career as an international Sales Manager, Tassilo Korab has been in the packaging industry for more than 20 years. A recognised expert in flexible packaging, he holds an MSc in Healthcare Economics, and has written several publications on patient compliance, standards and regulations for child resistant packaging and the war against counterfeits. Tassilo is currently Managing Director of TKM Handels GmbH, Vienna, a consulting company in the sector of flexible packaging for the pharmaceutical and healthcare industries. He was one of the co-founders of HCPC-Europe, the Healthcare Compliance Packaging Council, a not-for-profit organisation uniting the pharmaceutical industry, packaging materials suppliers, packaging machine manufacturers and patient organisations in their common endeavour to improve drug packaging design in the interest of the patients. He has been Executive Director since September 2005.
spacer
Tassilo Korab
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Nemera breaks ground in Brazil through Milfra acquisition

With this acquisition Nemera establishes an operational footprint in Brazil and expands its product and services offering to better serve the pharmaceutical industry in Latin America. Nemera today announced that they have entered into an agreement to acquire Milfra. Milfra, based in Jaguariuna, state of São Paulo, Brazil, specializes in the development and production of both vaginal and rectal applicators, as well as oral dosers for the pharmaceutical industry.
More info >>

White Papers

What Your Clinical Study Design Reveals About Your Clinical Packaging Needs

PCI Pharma Services

As the cost and complexities of drug development increase, so do the challenges of global clinical trials. Today’s sponsors must be able to manage and coordinate multiple resources, processes, and locations with speed and accuracy to design effective and efficient clinical trials. Securing a stable supply chain to deal with the uncertainties of clinical trials is critical. One misstep can have a profound impact not only on the cost and time of your trial but also on its overall success.
More info >>

 

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement